BARRON’S MAGAZINE – MAY 8, 2023 ISSUE

Culture Wars Are Hitting Companies. How They’re Fighting Back.

Bud Light is the latest casualty in a battle over whether companies are embracing too many progressive goals on everything from gender identity to climate change. What’s at stake as companies fight back.

Thinking of Buying Bank Stocks? You’ll Need a Strong Stomach.

No one wants to buy bank stocks ahead of a recession, says UBS analyst Erika Najarian.

Weight-Loss Drugs Will Be Blockbusters. Here’s the Stock to Buy.

Everyone is talking about Eli Lilly’s Mounjaro and Novo Nordisk’s Ozempic. Now, the drugs are poised to go from conversation starters to profit makers.

Biofuel Stocks Are Sputtering. They Could Get a Jump Start.

An industry reckoning over carbon credits could refresh the market for renewables derived from things such as cooking oil and cow manure. These beaten-down stocks that could get a lift once headwinds subside.

@barronsonline December 12, 2022 issue:

Retirees Put Their Lives on Hold for Covid. Inflation Is Forcing Them to Do It Again.

“Nobody budgets this kind of inflation.” How retirees are responding to the fastest-rising prices in 40 years.

Cash Yields Are a Bright Spot for Retirees. Here’s How Much You Need.

High inflation and the volatile stock market have wreaked havoc on people’s retirement plans. Cash—handled correctly—can provide some relief.

CVS Wants to Be America’s Healthcare Provider. All It Needs Now Are Doctors.

The company’s big bet on primary care hasn’t yet come to pass. Should investors be worried?

This Industrial Stock Could Soar 40%

Investors are punishing Regal Rexnord for acquiring Altra Industrial Motion as the economy weakens. Those concerns are overblown.

The Lesson of Blackstone’s Retail Real Estate Fund: Liquidity Matters

The firm’s nontraded real estate income trust, BREIT, was a big success until the turmoil of 2022. When redemption requests mounted, the firm limited them, raising a raft of issues, from fears of outflows to regulatory scrutiny.